Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Laruelle

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Synapse (New York, N.Y.)|June 3, 2009
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic miceEugenii A Rabiner, Mark Slifstein, Jose Nobrega, et al.
Neuroimage|April 22, 2010
Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brainN V Murthy, S Selvaraj, P J Cowen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curvesR B Innis, M S al-Tikriti, S S Zoghbi, et al.
Journal of Psychopharmacology (Oxford, England)|January 17, 2014
Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PETKhanum Ridler, Roger N Gunn, Graham E Searle, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 14, 2010
Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancySergio Abanades, Jasper van der Aart, Julien A R Barletta, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Synapse (New York, N.Y.)|June 3, 2009
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic miceEugenii A Rabiner, Mark Slifstein, Jose Nobrega, et al.
Neuroimage|April 22, 2010
Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brainN V Murthy, S Selvaraj, P J Cowen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curvesR B Innis, M S al-Tikriti, S S Zoghbi, et al.
Journal of Psychopharmacology (Oxford, England)|January 17, 2014
Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PETKhanum Ridler, Roger N Gunn, Graham E Searle, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 14, 2010
Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancySergio Abanades, Jasper van der Aart, Julien A R Barletta, et al.
Pageof 1